HomeNDC LookupRxCUI directory › RxCUI 1088249

Docusate sodium 3.33 MG/ML Oral Solution [Pedia-Lax Liquid] — RxCUI 1088249

RxNorm drug concept · Semantic branded drug
RxCUI 1088249 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1088249
Official nameDocusate sodium 3.33 MG/ML Oral Solution [Pedia-Lax Liquid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPedia-Lax Liquid 3.33 MG/ML Oral Solution; Pedia-Lax Stool Softener 50 MG in 15 mL Oral Solution; DOSS Sodium 3.33 MG/ML Oral Solution [Pedia-Lax Liquid]; Pedia-Lax Stool Softener 50 MG per 15 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Docusate sodium 3.33 MG/ML Oral Solution [Pedia-... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Docusate sodium 3.33 MG/ML Oral Solution [Pedia-Lax Liquid] RxCUI 1088249

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Docusate 82003
    • Docusate sodium 71722
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pedia-Lax Liquid 1088246
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Docusate Oral Solution 371945
    • Docusate sodium Oral Solution 2645348
    • Docusate Oral Liquid Product 1160199
    • Docusate Oral Product 1160200
    • Docusate sodium Oral Liquid Product 2663250
    • Docusate sodium Oral Product 2661151
    • Docusate Oral Solution [Pedia-Lax Liquid] 1088248
    • Docusate sodium Oral Solution [Pedia-Lax Liquid] 2657444
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Docusate sodium 3.33 MG/ML Oral Solution SCD · 1088245
  • Docusate sodium 3.33 MG/ML SCDC · 1088244
  • Docusate Oral Solution SCDF · 371945
  • Docusate sodium Oral Solution SCDFP · 2645348
  • Docusate Oral Liquid Product SCDG · 1160199
  • Docusate Oral Product SCDG · 1160200
  • Docusate sodium Oral Liquid Product SCDGP · 2663250
  • Docusate sodium Oral Product SCDGP · 2661151

Brand-Name Concepts

  • Docusate sodium 3.33 MG/ML [Pedia-Lax Liquid] SBDC · 1088247
  • Docusate Oral Solution [Pedia-Lax Liquid] SBDF · 1088248
  • Docusate sodium Oral Solution [Pedia-Lax Liquid] SBDFP · 2657444
  • Pedia-Lax Liquid Oral Liquid Product SBDG · 1182944
  • Pedia-Lax Liquid Oral Product SBDG · 1182945
  • Pedia-Lax Liquid BN · 1088246

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1088249 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00132-0113-24 118 mL in 1 CARTON (0132-0113-24) Pedia-Lax C.B. Fleet Company, Inc. 2023-02-28
Observed labelers: C.B. Fleet Company, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.